Literature DB >> 18721321

Allergy and the gastrointestinal system.

G Vighi1, F Marcucci, L Sensi, G Di Cara, F Frati.   

Abstract

The gastrointestinal system plays a central role in immune system homeostasis. It is the main route of contact with the external environment and is overloaded every day with external stimuli, sometimes dangerous as pathogens (bacteria, protozoa, fungi, viruses) or toxic substances, in other cases very useful as food or commensal flora. The crucial position of the gastrointestinal system is testified by the huge amount of immune cells that reside within it. Indeed, gut-associated lymphoid tissue (GALT) is the prominent part of mucosal-associated lymphoid tissue (MALT) and represents almost 70% of the entire immune system; moreover, about 80% of plasma cells [mainly immunoglobulin A (IgA)-bearing cells] reside in GALT. GALT interacts strictly with gastrointestinal functions in a dynamic manner; for instance, by increasing intestinal permeability in replay to particular stimulations, or orientating the immune response towards luminal content, allowing either tolerance or elimination/degradation of luminal antigens, or sometimes provoking damage to the intestinal mucosa, such as in coeliac disease or food allergy. The immune mechanisms implicated in these actions are very complex and belong to both innate and adaptive immunity; innate immunity supplies an immediate non-specific response that is indispensable before specific adaptive immunity, which needs 7-10 days to be efficacious, takes place. The results of their interactions depend upon different contexts in which contact with external agents occurs and may change according to different genetic settings of the hosts.

Entities:  

Mesh:

Year:  2008        PMID: 18721321      PMCID: PMC2515351          DOI: 10.1111/j.1365-2249.2008.03713.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii.

Authors:  Laurie A Minns; Laurence C Menard; David M Foureau; Sylvie Darche; Catherine Ronet; Daniel W Mielcarz; Dominique Buzoni-Gatel; Lloyd H Kasper
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

Review 2.  Eosinophilic esophagitis: an update.

Authors:  D D Ferguson; A E Foxx-Orenstein
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

Review 3.  The development of food allergy after liver transplantation.

Authors:  Robert J Boyle; Winita Hardikar; Mimi L K Tang
Journal:  Liver Transpl       Date:  2005-03       Impact factor: 5.799

Review 4.  The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora?

Authors:  A E Wold
Journal:  Allergy       Date:  1998       Impact factor: 13.146

Review 5.  Oral tolerance.

Authors:  Ana M C Faria; Howard L Weiner
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

6.  CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.

Authors:  Miao Qiao; Angela M Thornton; Ethan M Shevach
Journal:  Immunology       Date:  2007-01-17       Impact factor: 7.397

Review 7.  Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections.

Authors:  Stuart E Turvey; Thomas R Hawn
Journal:  Clin Immunol       Date:  2006-03-24       Impact factor: 3.969

Review 8.  Food allergy. Part 1: immunopathogenesis and clinical disorders.

Authors:  H A Sampson
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

9.  Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up.

Authors:  Mirna Chehade; Margret S Magid; Shideh Mofidi; Anna Nowak-Wegrzyn; Hugh A Sampson; Scott H Sicherer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-05       Impact factor: 2.839

10.  Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses.

Authors:  Y Wang; Y Mei; S Bao; L Xu
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

View more
  68 in total

1.  Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.

Authors:  Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

Review 3.  Identifying human and murine M cells in vitro.

Authors:  Ana Klisuric; Benjamin Thierry; Ludivine Delon; Clive A Prestidge; Rachel J Gibson
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-24

4.  One veterinarian's experience with owners who are feeding raw meat to their pets.

Authors:  Lea Stogdale
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

5.  Gut Microbiota, the Immune System, and Cytotoxic T Lymphocytes.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  Methods Mol Biol       Date:  2021

6.  Treg Cells and Epigenetic Regulation.

Authors:  Joseph A Bellanti; Dongmei Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Gut reactions: How the blood-brain barrier connects the microbiome and the brain.

Authors:  Aric F Logsdon; Michelle A Erickson; Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-23

8.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

9.  Treg-inducing capacity of genomic DNA of Bifidobacterium longum subsp. infantis.

Authors:  Dongmei Li; Jie Cheng; Ziang Zhu; Marta Catalfamo; David Goerlitz; Oliver J Lawless; Luke Tallon; Lisa Sadzewicz; Richard Calderone; Joseph A Bellanti
Journal:  Allergy Asthma Proc       Date:  2020-09-01       Impact factor: 2.587

10.  Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Authors:  Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.